Citations

Showing 10 of 108104 citations.

Cerebral Artery Vasospasm Detection Using Transcranial Doppler Signal Analysis
Elzaafarany, Khaled , Kumar, Gyanendra , Nakhmani, Arie , Nakhmani, Arie , Aly, Moustafa H.

Mayo Clinic

Journal of Ultrasound in Medicine | December 29, 2018 | Volume: 38 | Issue: 8 | Pages: 2191-2202

10.1002/jum.14916 | PMID 30593699 Get It

ObjectivesSilent cerebral artery vasospasm in aneurysmal subarachnoid hemorrhage causes serious complications such as cerebral ischemia and death. A transcranial Doppler (TCD) ultrasound system is a noninvasive device that can effectively detect cerebral artery vasospasm as soon as it sets in, even before and in the absence of clinical deterioration. Continuous or even daily TCD monitoring is challenging because of the operator expertise and certification required in the form of a trained sonographer and interpretive experience required in the form of an additionally trained and certified physician to perform these studies. This barrier exists because of a lack of automation for detection (without human intervention) of cerebral artery vasospasm using TCD ultrasound. To overcome this barrier, we present an algorithm that automates detection of cerebral artery vasospasm.MethodsWe extracted features such as the energy, energy entropy, zero‐crossing rate, spectral centroid, spectral speed, spectral entropy, spectral flux, spectral roll‐off, harmonic ratio, chroma, and Mel frequency cepstral coefficients for signal classification. Then we applied principal component analysis to reduce the data dimensionality.ResultsAll of the chosen features were used for training a decision‐tree classifier. The algorithm had high accuracy for cerebral artery vasospasm detection, with overall sensitivity of 87.5% and specificity of 89.74%.ConclusionsThe algorithm has the potential for development into a continuous cerebral artery vasospasm monitor.
Does High Cerebral Microbleed Burden Increase the Risk of Intracerebral Hemorrhage After Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke?
Arca, Karissa N., Almader‐Douglas, Diana , Wingerchuk, Dean M. , O’Carroll, Cumara B. , Almader-Douglas, Diana, Demaerschalk, Bart M.

Mayo Clinic

The Neurologist | December 29, 2018 | Volume: 24 | Issue: 1 | Pages: 40-43

10.1097/nrl.0000000000000228 | PMID 30586035 Get It

Background: The risk of developing intracerebral hemorrhage (ICH) after the administration of intravenous tissue plasminogen activator for acute ischemic stroke is well established in the general population. However, the risk associated with stroke thrombolysis in patients with a history of cerebral microbleeds (CMBs) is undetermined. Objective: The main objective of this study was to critically assess current evidence with regard to the risk of development of ICH after the administration of intravenous tissue plasminogen activator for acute ischemic stroke in patients with CMBs. Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, literature search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom-line conclusions. Participants included consultant and resident neurologists, a medical librarian, clinical epidemiologists, and content experts in the field of vascular and hospital neurology. Results: A recent individual patient data meta-analysis was selected for critical appraisal. Cohorts were analyzed with pretreatment magnetic resonance imaging to determine CMB burden and were followed-up to assess subsequent symptomatic ICH, hemorrhagic transformation, parenchymal hemorrhage (PH), and remote PH (PHr) following intravenous thrombolysis. Risk of symptomatic ICH, PH, and PHr was increased in the presence of CMBs, with PHr having the strongest association with increasing CMB burden. Only patients with >10 CMBs were found to have associations with poor outcome at 3 to 6 months, whereas there was no association with 3 to 6 months’ mortality. Conclusions: CMBs are associated with an increased risk of postthrombolysis ICH; however, the clinical implications have yet to be determined.
Are Postprocedural Blood Pressure Goals Associated With Clinical Outcome After Mechanical Thrombectomy for Acute Ischemic Stroke?
Blech, Benzion , Chong, Brian W. , Sands, Kara, Wingerchuk, Dean M. , Jackson, W. Thomas, Marks, Lisa , O’Carroll, Cumara B. , Marks, Lisa A., Marks, Lisa A , Jackson, William T.

Mayo Clinic

The Neurologist | December 29, 2018 | Volume: 24 | Issue: 1 | Pages: 44-47

10.1097/nrl.0000000000000223 | PMID 30586036 Get It

Mechanical thrombectomy (MT) is the standard of care for patients who present with an acute ischemic stroke within 6 hours of symptom onset, and up to 24 hours in appropriately selected patients. However, optimal postoperative management of these patients remains uncertain, especially with regard to blood pressure control. To review the existing literature to define potential blood pressure goals in the immediate postoperative period in patients who undergo MT for acute ischemic stroke. The topic was defined through a clinical scenario and the subsequent development of a targeted clinical question. A literature search was performed, with relevant articles selected, one of which, a prospective observational study, was critically appraised. Participants included neurology residents and consultants, a medical librarian, clinical epidemiologists, as well as content experts from vascular neurology and interventional neuroradiology. Permissive hypertension (defined as <220/120 or <180/105 mm Hg as per the American Heart Association/American Stroke Association guidelines) may be harmful in the postoperative period following MT, especially in patients who were successfully recanalized. Moderate blood pressure control (<160/90) was found to be a predictor of improved 3-month mortality on multivariable logistic regression analysis in patients who sustained successful reperfusion [odds ratio (OR), 0.08; 95% confidence interval (CI), 0.01-0.054; P=0.01]. A 10 mm Hg increase in systolic blood pressure was found to result in a lower OR of having a favorable 3-month functional independence (OR, 0.70; 95% CI, 0.56-0.85; P=0.001) as well as higher rates of 3-month mortality (OR, 1.49; 95% CI, 1.18-1.88; P=0.001). Blood pressure goals in the immediate postoperative period in patients who undergo MT should differ than those who do not undergo MT, with data suggesting that lower blood pressure than permissive hypertension may be related to improved outcomes, especially in cases of successful reperfusion. However, current data are derived from observational studies; further studies, preferably in the form of randomized-controlled trials, are needed to further clarify the relationship between postoperative blood pressures and outcomes in this patient population.
Transcranial Doppler Evaluation in Takayasu Arteritis With Oculo-Cerebrovascular Complications
Christiansen, Michael E., O’Carroll, Cumara B. , Kumar, Gyanendra , Larsen, Brandon T. , Dumitrașcu, Oana

Mayo Clinic

The Neurologist | December 29, 2018 | Volume: 24 | Issue: 1 | Pages: 17-21

10.1097/nrl.0000000000000202 | PMID 30586029 Get It

Introduction: Takayasu arteritis is a large-vessel vasculitis that may cause oculo-cerebral ischemia. We report a patient with visual loss as initial manifestation, and discuss transcranial Doppler (TCD) findings before and after surgical revascularization. Case Description: A 19-year-old female developed episodes of transient positional right vision loss, progressing to permanent right vision loss and bright light-induced left amaurosis. Examination demonstrated subclavian bruits, palpable epigastrium aortic pulsation, faint radial pulses, right retinal pallor, arteriolar narrowing, and bilateral boxcarring. Head and neck computed tomography angiogram demonstrated left subclavian origin and right common carotid artery occlusion, and severe innominate and left common carotid artery stenosis. TCD demonstrated right ophthalmic artery flow reversal and nonpulsatile waveforms with dampened spectra in the right anterior circulation. Corticosteroids, methotrexate, infliximab, and dual-antiplatelet therapy were initiated. Eleven weeks later, the patient underwent ascending aortic aneurysm repair and bilateral carotid artery bypass with an aortic graft. Pathology was consistent with chronic active Takayasu arteritis. Two weeks postoperatively, left eye visual symptoms resolved; right visual loss persisted. Postoperative TCD showed marked improvement in cerebral perfusion. Conclusions: Retinal ischemia in young women should prompt emergent inflammatory and systemic vascular evaluation. In our subject, prolonged right retinal ischemia had dismal prognosis despite carotid-aortic revascularization, whereas left retinal boxcarring reversed. Surgical revascularization is recommended for severely symptomatic oculo-cerebrovascular disease, once inflammation is better controlled with immunosuppressive therapy. TCD documented the presence and monitored the subsequent resolution of blood flow changes causing retinal and brain hypoxia.
Reply to H.J.A. Adams et al
Shi, Qian , Flowers, Christopher R. , Shi, Qian

Mayo Clinic

Journal of Clinical Oncology | December 28, 2018 | Volume: 37 | Issue: 6 | Pages: 526-527

10.1200/jco.18.02022 | PMID 30592641 Get It

A Model to Study Thermal Energy Delivery to the Choroid: A Comparison of Surgical Devices
Tailor, Prashant D. , Gandhi, Jarel K. , Loftness, Paul, Olsen, Timothy W. , LoBue, Stephen A , Tailor, Prashant D

Mayo Clinic

Translational Vision Science & Technology | December 28, 2018 | Volume: 7 | Issue: 6 | Pages: 39

10.1167/tvst.7.6.39 | PMID 30619659 Get It

Confocal Microscopy Changes in Epithelial and Stromal Thickness up to 7 Years After LASIK and Photorefractive Keratectomy for Myopia
Erie, Jay C., McLaren, Jay W. , Bourne, William M., Patel, Sanjay V.

Mayo Clinic

Journal of Refractive Surgery | December 28, 2018 | Volume: 23 | Issue: 4 | Pages: 385-392

10.3928/1081-597x-20070401-11 | PMID 17455834 Get It

Purpose: To determine the long-term changes in epithelial, stromal, and corneal thickness after LASIK and photorefractive keratectomy (PRK). Methods: In two prospective observational case series, 11 patients (16 eyes) received LASIK and 12 patients (18 eyes) received PRK to correct myopia or myopic astigmatism. None of the corneas had retreatment procedures. Corneas were examined using confocal microscopy before and at 1 month, and at 1, 2, 3, 5, and 7 years after surgery. Central thicknesses were measured from reflected light intensity profiles recorded by confocal microscopy. Postoperative epithelial thickness was compared to preoperative, and postoperative stromal and corneal thicknesses were compared to thickness at 1 month after surgery. Results: In LASIK, epithelial thickness at 1 month (51±4 µ m, n=11) was greater than before surgery (41±4 µ m, n=16; P <.001) and remained thicker through 7 years (52±6 µ m, n=13; P <.001). Stromal and corneal thickness did not change between 1 month and 7 years after LASIK. After PRK, corneal thickness at 1 year (464±44 µ m, n=17) was greater than at 1 month (442±39 µ m, n=15; P =.001) and remained thicker at 7 years after PRK (471±45 µ m, n=17; P <.001). Conclusions: The early increase in central epithelial thickness after myopic LASIK persists for at least 7 years and is probably the result of epithelial hyperplasia. Central corneal thickness increases during the first year after PRK and remains stable thereafter up to 7 years. [ J Refract Surg . 2007;23:385–392.]
Faculty Opinions recommendation of Age-related declines in α-Klotho drive progenitor cell mitochondrial dysfunction and impaired muscle regeneration.
LeBrasseur, Nathan K.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 28, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.734467118.793554540 Get It

Temporal Annotation in the Clinical Domain
Styler, William F., Finan, Sean , Pradhan, Sameer , Groen, Piet C. de , Erickson, Brad, Lin, Chen, Savova, Guergana , Pustejovsky, James , Bethard, Steven J. , Palmer, Martha , Miller, Timothy A.

Mayo Clinic

Transactions of the Association for Computational Linguistics | December 28, 2018 | Volume: 2 | Issue: No issue available | Pages: 143-154

10.1162/tacl_a_00172 Get It

This article discusses the requirements of a formal specification for the annotation of temporal information in clinical narratives. We discuss the implementation and extension of ISO-TimeML for annotating a corpus of clinical notes, known as the THYME corpus. To reflect the information task and the heavily inference-based reasoning demands in the domain, a new annotation guideline has been developed, “the THYME Guidelines to ISO-TimeML (THYME-TimeML)”. To clarify what relations merit annotation, we distinguish between linguistically-derived and inferentially-derived temporal orderings in the text. We also apply a top performing TempEval 2013 system against this new resource to measure the difficulty of adapting systems to the clinical domain. The corpus is available to the community and has been proposed for use in a SemEval 2015 task.
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi‐parametric flow cytometry method
Sidana, Surbhi , Jevremović, Dragan , Tandon, Nidhi , Gertz, Morie A. , Greipp, Patricia T. , Lacy, Martha Q. , Morice, William G. , Hanson, Curtis A. , Timm, Michael, Dingli, David , Hayman, Suzanne R. , Kapoor, Prashant , Kyle, Robert A. , Lust, John A., Kumar, Shaji , Tandon, Nidhi , Gertz, Morie A , Buadi, Francis K. , Morice, William, Hanson, Curtis, Gonsalves, Wilson , Leung, Nelson , Go, Ronald S , Rajkumar, S Vincent , Kumar, Shaji K , Jevremovic, Dragan , Sidana, Surbhi , Dingli, David , Greipp, Patricia T , Ketterling, Rhett P. , Dispenzieri, Angela , Baughn, Linda B. , Morice, William George , Gonsalves, Wilson I. , Leung, Nelson , Go, Ronald S. , Rajkumar, S. Vincent

Mayo Clinic

American Journal of Hematology | December 28, 2018 | Volume: 94 | Issue: 4 | Pages: 424-430

10.1002/ajh.25391 | PMID 30592078 Get It

AbstractTrisomies of odd numbered chromosomes are seen in nearly half of patients with multiple myeloma (MM) and typically correlate with a hyperdiploid state and better overall survival (OS). We compared DNA ploidy of monoclonal plasma cells (as a surrogate for the presence of trisomies) assessed simultaneously by PCPRO (plasma cell proliferative index), a novel method that estimates DNA index by multi‐parametric flow cytometry to fluorescence in situ hybridization (FISH) in 1703 patients with plasma cell disorders. The distribution of ploidy was hyperdiploid: 759 (45%), diploid 765 (45%), hypodiploid: 71 (4%), tetraploid/near‐tetraploid: 108 (6%). FISH identified trisomies in 82% (621/756) of patients with hyperdiploidy by PCPRO and no trisomy by FISH was observed in 88% (730/834) of patients without hyperdiploidy. 95% (795/834) of patients without hyperdiploidy on PCPRO had one or less trisomy by FISH. Sensitivity and specificity of PCPRO for detecting hyperdiploidy was 86% (621/725) and 84% (730/865), respectively. Sensitivity increased to 94% (579/618) for patients with more than one trisomy. Newly diagnosed MM patients with hyperdiploidy on PCPRO (147/275) had better OS compared to nonhyperdiploid patients (median not reached vs 59 months, P = 0.008) and better progression free survival (median: 33 vs 23 months, P = 0.03). Within the hyperdiploidy group, patients with high‐hyperdiploidy (DNA index: 1.19‐1.50) versus those with low‐hyperdiploidy (DNA index: 1.05‐1.18) had superior OS (3 year OS of 88% vs 68% P = 0.03). Ploidy assessment by flow cytometry can provide rapid, valuable prognostic information and also reduces the number of copy number FISH probes required and hence the cost of FISH.